找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Marshall and the Marshallian Heritage; Essays in Honour of Katia Caldari,Marco Dardi,Steven G. Medema Book 2021 The Editor(s) (if applicab

[復(fù)制鏈接]
樓主: 拿著錫
11#
發(fā)表于 2025-3-23 12:45:28 | 只看該作者
Destabilizing Speculation on Organized Markets: Early Perspectives in the Spirit of Marshalles. As the number of amateurs increases, so does the incentive for professionals to devote their resources to anticipating short-run fluctuations in amateur opinion, which may have little if any connection with fundamentals. Based on these analytical considerations, Marshall endorsed the use of futu
12#
發(fā)表于 2025-3-23 14:58:56 | 只看該作者
Industrial Leadership, Market Power and Long-Term Performance: Marshall’s and Keynes’s Appreciation cepticism about the future of trusts and big business during the 1890s, his confidence in the leaders of American industry and their dynamism resurfaced in ., where he described the leaders of big business in America as inspired by the same spirit of innovation he had observed in 1875. The ideas tha
13#
發(fā)表于 2025-3-23 22:01:38 | 只看該作者
14#
發(fā)表于 2025-3-24 00:19:15 | 只看該作者
15#
發(fā)表于 2025-3-24 06:10:37 | 只看該作者
16#
發(fā)表于 2025-3-24 09:38:17 | 只看該作者
17#
發(fā)表于 2025-3-24 12:55:09 | 只看該作者
18#
發(fā)表于 2025-3-24 15:37:35 | 只看該作者
19#
發(fā)表于 2025-3-24 21:12:58 | 只看該作者
Cosimo PerrottaMTAs. We also present their effects on the immune system, which may contribute to the antitumour efficacy of MTA-based metronomic chemotherapy. Then, we review the results obtained with this type of therapeutic approach in preclinical models of human cancer, focusing on the most promising combinatio
20#
發(fā)表于 2025-3-25 00:07:29 | 只看該作者
Neil Hartse studies. Nevertheless, metronomic chemotherapy can serve as a treatment option for advanced HCC patients who have progressed on or are intolerable to the standard therapy, sorafenib. In single-arm phase II clinical trials, combining metronomic chemotherapy with antiangiogenic targeted therapy has
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-27 02:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
大邑县| 崇左市| 兰考县| 两当县| 保靖县| 文水县| 永安市| 平果县| 抚顺县| 舒城县| 志丹县| 建德市| 庄浪县| 高青县| 靖远县| 新龙县| 通河县| 上思县| 静宁县| 五台县| 博白县| 曲麻莱县| 许昌市| 岚皋县| 满洲里市| 深圳市| 民勤县| 拜城县| 临猗县| 肥东县| 郸城县| 博罗县| 宁南县| 华亭县| 澄江县| 永仁县| 临沧市| 丹棱县| 临沧市| 新田县| 德庆县|